We have aimed to advance the understanding of the molecular mechanisms involved in tau aggregation and propagation for all neurodegenerative tauopathies, but also to consider TBI as a complex environmental risk factor that can predispose to and drive pathology in unique ways, thus requiring future research to achieve a deeper understanding of this process. The gene discussed is MAPT; the disease is tauopathy.